Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

0.6660
-0.0088-1.30%
Post-market: 0.68000.0140+2.10%19:49 EDT
Volume:2.05M
Turnover:1.38M
Market Cap:123.94M
PE:-1.05
High:0.6941
Open:0.6866
Low:0.6590
Close:0.6748
Loading ...
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 11, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 07, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jul 04, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities